98%
921
2 minutes
20
Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine and metabolic condition among women of reproductive age, frequently associated with oxidative stress (OS) and chronic low-grade inflammation. Low-Intensity pulsed ultrasound (LIPUS) is a safe, non-invasive physical therapy method widely used in promoting fracture healing, soft tissue repair, and reducing inflammation. This study explored the improving effect of LIPUS on ovarian function in PCOS rat models induced by letrozole and a high-fat diet. The results showed that LIPUS could significantly reduce ovarian weight, improve estrous cycle disorder, decrease testosterone, inflammation and OS levels in vitro and in vivo. Also, the number of cystic follicles in LIPUS-treated rats decreased, while the number of corpora lutea increased, indicating improved follicular development. LIPUS intervention markedly downregulated the mRNA and protein expression levels of inflammatory mediators (TNF-α, IL-1β, and IL-6) and the pro-apoptotic factor (BAX) in the ovaries of PCOS rats, while upregulating the expression level of the anti-apoptotic factor (BCL-2). Moreover, we also discovered that LIPUS significantly decreased NF-κB signaling pathway. As a result, this study provides new insight into the mechanism by which LIPUS improve the function of the ovaries in PCOS rats, offering a promising approach for the clinical treatment of PCOS.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bcp.2025.117281 | DOI Listing |
Life Sci
August 2025
Department of Pharmacology and Toxicology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), P.O. Box 77, Giza, Egypt. Electronic address:
Aims: Polycystic ovarian syndrome (PCOS) is a hormonal disorder affecting females worldwide. PCOS is associated with the development of depression, which is exacerbated by oxidative stress, neuro-inflammation, and ferropotosis. Rebamipide (Reba) is a potent antioxidant agent exhibiting cytoprotective effects.
View Article and Find Full Text PDFJ Drug Target
September 2025
Department of Pharmaceutics, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard, New Delhi, India.
Polycystic ovarian syndrome is a highly prevalent, multifaceted endocrinopathy among reproductive women. Current therapies have limited therapeutic success and compliance owing to multiple complications. Here, we developed MPPs-Gel formulation for efficient targeted intravaginal delivery that addresses the complementary mechanism of insulin resistance and other associated disorders.
View Article and Find Full Text PDFBiochem Pharmacol
August 2025
The First Affiliated Hospital, Gynecology &Obstetrics and Reproductive Medical Center, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China
Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine and metabolic condition among women of reproductive age, frequently associated with oxidative stress (OS) and chronic low-grade inflammation. Low-Intensity pulsed ultrasound (LIPUS) is a safe, non-invasive physical therapy method widely used in promoting fracture healing, soft tissue repair, and reducing inflammation. This study explored the improving effect of LIPUS on ovarian function in PCOS rat models induced by letrozole and a high-fat diet.
View Article and Find Full Text PDFNaunyn Schmiedebergs Arch Pharmacol
August 2025
Pharmacology Department, Faculty of Medicine, Tanta University, Tanta, 31527, Egypt.
Polycystic ovary syndrome (PCOS) is the most prevalent endocrinopathy affecting women in the reproductive age range, which is thought to be the primary cause of anovulatory infertility. This condition is complex and heterogeneous. The current study is aimed at determining the potential ameliorative effects of bromelain and metformin, either separately or in combination, in the reduction of letrozole-induced PCOS in female rats by focusing on the inflammatory axis, homeostasis model assessment of insulin resistance (HOMA-IR), and silencing information regulator 2-related enzyme 1 (SIRT1).
View Article and Find Full Text PDFNaunyn Schmiedebergs Arch Pharmacol
August 2025
Specialized Healthcare and Medical Education Department, Lahore, Punjab, 54000, Pakistan.
Polycystic ovary syndrome (PCOS) is a complicated endocrine disease marked by hyperandrogenism, inflammation, hyperglycemia, and disrupted ovulation. This research examined the therapeutic effect of cinnamaldehyde in alleviating PCOS-associated complications in rats administered with letrozole. Letrozole-induced PCOS rats exhibit symptoms similar to human PCOS, including hormonal imbalance, insulin resistance, and dyslipidemia.
View Article and Find Full Text PDF